A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSt. Mary's University, Twickenham
About this trial
A small-scale test of the intervention, trial design and methods to explore the cumulative effectiveness of two commonly used prescribing strategies for patients with long COVID: Treatment A - prescribing a specific homeopathic remedy for long COVID, plus or minus Treatment B - a course of individually tailored treatment by a homeopath. Both interventions compared to usual care
Eligibility criteria
Qualifiers
Adults who experienced acute COVID-19 at least 12 weeks ago
A medical diagnosis of long COVID (diagnosis by a healthcare professional, documentation from an NHS long COVID clinic, or equivalent formal medical verification)
At least one recognized long COVID symptom according to NHS criteria
Agreement to be contacted again and interest in participating in research.
Disqualifiers
Those who have not had acute COVID-19
Those who have not received a medical diagnosis of long COVID
Those not currently experiencing symptoms (MYMOP average score 1 or less)
Inability to give informed consent
Trial design
Treatments tested in this trial
- Treatment A: Treatment by a homeopath prescribing a specific homeopathic remedy for long COVID
- a course of individually tailored treatment by a homeopath
Treatment groups
120 Participants
are divided into 3 treatment groupsSponsors and collaborators
St. Mary's University, Twickenham
Lead sponsor
Institute for Ethical Research Governance
Collaborator
Homeopathy International
Collaborator
Source ClinicalTrials.gov